Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$26.26 - $31.38 $21,296 - $25,449
-811 Reduced 4.1%
18,972 $515,000
Q2 2023

Jul 26, 2023

BUY
$29.6 - $36.56 $585,576 - $723,266
19,783 New
19,783 $608,000
Q2 2022

Aug 03, 2022

SELL
$37.53 - $44.22 $241,017 - $283,980
-6,422 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$37.46 - $42.44 $3,820 - $4,328
-102 Reduced 1.56%
6,422 $250,000
Q4 2021

Jan 27, 2022

BUY
$35.17 - $42.48 $229,449 - $277,139
6,524 New
6,524 $260,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.